Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Net Margin (2016 - 2025)

Historic Net Margin for Abeona Therapeutics (ABEO) over the last 13 years, with Q2 2025 value amounting to 28416.75%.

  • Abeona Therapeutics' Net Margin changed N/A to 28416.75% in Q2 2025 from the same period last year, while for Sep 2025 it was 21811.75%, marking a year-over-year change of. This contributed to the annual value of 1548.57% for FY2023, which is 15278100.0% up from last year.
  • According to the latest figures from Q2 2025, Abeona Therapeutics' Net Margin is 28416.75%.
  • Abeona Therapeutics' Net Margin's 5-year high stood at 97256.25% during Q4 2021, with a 5-year trough of 10441.18% in Q4 2022.
  • In the last 4 years, Abeona Therapeutics' Net Margin had a median value of 1013.8% in 2021 and averaged 12349.09%.
  • As far as peak fluctuations go, Abeona Therapeutics' Net Margin soared by 977838500bps in 2021, and later tumbled by -1076974300bps in 2022.
  • Quarter analysis of 4 years shows Abeona Therapeutics' Net Margin stood at 97256.25% in 2021, then tumbled by -111bps to 10441.18% in 2022, then surged by 95bps to 475.83% in 2023, then surged by 6072bps to 28416.75% in 2025.
  • Its last three reported values are 28416.75% in Q2 2025, 475.83% for Q2 2023, and 10441.18% during Q4 2022.